rs4075958

This is a regulatory region variant variant in the RGS14 gene.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

hematocrit

Allele A
OR 0.02
p 3.0e-36
N 928,679
Large GWAS
multi-ancestry
Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele A
OR 0.02
p 7.0e-26
N 503,490
Large GWAS
multi-ancestry
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.03
p 5.0e-30
N 408,112
Large GWAS
European

erythrocyte count

Allele A
OR 0.02
p 2.0e-34
N 928,679
Large GWAS
multi-ancestry
Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele A
OR 0.02
p 2.0e-30
N 503,987
Large GWAS
multi-ancestry
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.03
p 9.0e-29
N 408,112
Large GWAS
European

hemoglobin measurement

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.03
p 1.0e-27
N 408,112
Large GWAS
European
Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele A
OR 0.02
p 2.0e-23
N 502,921
Large GWAS
multi-ancestry

glomerular filtration rate

Allele A
OR 0.67
p 1.0e-16
N 58,406
Large GWAS
East Asian
Allele A
OR 5.73
p 1.0e-8
N 145,732
Large GWAS
multi-ancestry

ClinVar annotation

Benign☆☆☆
1 submitter
View on ClinVar →

Research that mentions this SNP (1)

Genetic variations in regulator of G‐protein signaling (RGS) confer risk of bladder cancer
AssociationN=1,606Eugene K. Lee et al.(2013)· Cancer

Case-control study of 803 bladder cancer patients and 803 healthy controls examining 95 SNPs in 17 RGS (Regulator of G-Protein Signaling) pathway genes. Rs10759 in RGS4 showed the strongest association with reduced bladder cancer risk (OR 0.77, P<0.001), and cumulative analysis of 5 significant SNPs yielded OR 4.13 (95% CI 2.14-7.98) for high-risk genotype combinations. Eleven and thirteen SNPs were associated with recurrence and progression in non-muscle invasive bladder cancer (NMIBC); rs2344673 in RGS5 was most significant for death in muscle-invasive bladder cancer (MIBC), with median survival of 13.3 months vs 81.9 months.

Traits studied:Bladder cancer death/survivalBladder cancer progressionBladder cancer recurrenceBladder cancer riskMuscle-invasive bladder cancer (MIBC)Non-muscle invasive bladder cancer (NMIBC)

About RGS14

This gene encodes a member of the regulator of G-protein signaling family. This protein contains one RGS domain, two Raf-like Ras-binding domains (RBDs), and one GoLoco domain. The protein attenuates the signaling activity of G-proteins by binding, through its GoLoco domain, to specific types of activated, GTP-bound G alpha subunits. Acting as a GTPase activating protein (GAP), the protein increases the rate of conversion of the GTP to GDP. This hydrolysis allows the G alpha subunits to bind G beta/gamma subunit heterodimers, forming inactive G-protein heterotrimers, thereby terminating the signal. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]

View all RGS14 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…